Oncolytics Biotech Inc (TSX:ONC)
C$ 1.55 0.06 (4.03%) Market Cap: 119.13 Mil Enterprise Value: 95.39 Mil PE Ratio: 0 PB Ratio: 6.51 GF Score: 38/100

Oncolytics Biotech Inc Host Key Opinion Leader - Corporate Call Transcript

Apr 12, 2021 / 06:00PM GMT
Release Date Price: C$4.13 (-17.23%)
Operator

Good afternoon, and welcome to the Oncolytics KOL Webinar. (Operator Instructions) As a reminder, this conference is being recorded, and a replay will be made available on the Oncolytics Biotech website following the event.

I would now like to turn the call over to your host, Dr. Matt Coffey, President and Chief Executive Officer of Oncolytics Biotech. Please go ahead, doctor.

Matthew C. Coffey
Oncolytics Biotech Inc. - President, CEO & Director

Thank you, operator. So we're really quite excited about what we're accomplishing as a company. And I think today is the first time, I think, we've been able to express exactly how an agent like ours is actually able to cause a survival benefit. And I think, with our colleagues that will be presenting today, you'll have an opportunity to actually see how significant this actually is.

Now just a quick look to our forward-looking statements. What we plan on talking today is just an overview of what it is that we're trying to accomplish and how significant the results that we're presenting today

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot